Continual advances in human genetic sequences and genomics have transformed the area of medicine and clinical practices in myriad ways across the globe. The fast evolving era of personalized medicine in healthcare delivery has immensely improved our understanding of genetic characteristics and biomarkers for a range of diseases. Continuous developments in molecular biology and bioinformatics have expanded the applications of personalized medicine in designing specific diagnostics tools for cancer treatment and advanced newborn screening. Major global regulatory agencies across regions such as Food and Drug Administration (FDA) have added to the market growth by providing a conducive regulatory framework in conducting tests and breakthrough therapies in companion diagnostics. Big Market Research Reports comprehensively analyze the developments in personalized medicine and innovations in novel diagnostic platforms and next-generations. Insights into the strategies adopted by pharmaceutical and biotechnology companies to capitalize the potential opportunities in novel therapies are offered in the reports.
No of Reports 0